.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Antipsychotics, obesity, diabetes: Breaking the lock

March 22, 2004

Second-generation antipsychotics (SGAs), while clinically better than their earlier counterparts, have been associated with dramatic weight gain, diabetes and an atherogenic lipid profile.